Abstract
Cr (VI) compounds are widely used industrial chemicals and are recognized human carcinogens. The mechanisms of carcinogenesis associated with these compounds remain to be investigated. The present study focused on dose‐dependence of Cr (VI)‐induced uptake and cellular responses. The results show that Cr (VI) is able to enter the cells (human lung epithelial cell line A549) at low concentration (< 10 μM) and that the Cr (VI) uptake appears to be a combination of saturable transport and passive diffusion. Electron spin resonance (ESR) trapping measurements showed that upon stimulation with Cr (VI), A549 cells were able to generate reactive oxygen species (ROS). The amount of ROS generated depended on the Cr (VI) concentration. ROS generation involved NADPH‐dependent flavoenzymes. Cr (VI) affected the following cellular parameters in a dose-dependent manner, (a) activation of nuclear transcription factors NF-κB, and p53, (b) DNA damage, (c) induction of cell apoptosis, and (d) inhibition of cell proliferation. The activation of transcription factors was assessed by electrophoretic mobility shift assay and western blot analysis, DNA damage by single cell gel electrophoresis assay, cell apoptosis by DNA fragmentation assay, and cell proliferation by a non‐radioactive ELISA kit. At the concentration range used in the present study, no thresholds were found in all of these cell responses to Cr (VI). The results may guide further research to better understand and evaluate the risk of Cr (VI)‐induced carcinogenesis at low levels of exposure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
De Flora S, Bagnasco M, Serra D, Zanacchi P: Genotoxicity of chromium compounds: A review. Mutat Res 238: 99–172, 1990
Shi X, Chiu A, Chen CT, Halliwell B, Castranova V, Vallyathan V: Reduction of chromium (VI) and its relationship to carcinogenesis. J Toxicol Environ Health 2: 87–104, 1999
Deflora S, Wetterhahn KE: Mechanism of chromium metabolism and genotoxicity. Life Chem Rep 7: 169–244, 1989
Sugiyama M, Tsuzuki K, Haramaki N: DNA single-strand breaks and cytotoxicity induced by sodium chromate in hydrogen peroxide-resistant cell lines. Mutat Res 299: 95–102, 1993
Leonard S, Wang S, Zang L, Castranova V, Vallyathan V, Shi X: Role of molecular oxygen in the generation of hydroxyl and superoxide anion radicals during enzymatic Cr (VI) reduction and its implication to Cr (VI)-induced carcinogenesis. J Environ Pathol Toxicol Oncol 19: 49–60, 2000
Xu J, Wise JP, Patierno SR: DNA damage induced by carcinogenic lead chromate particles in cultured mammalian cells. Mutat Res 280: 129–136, 1992
Kortenkamp A, Ozolins Z, Beyersmann D, O'Brien P: Generation of PM2 DNA breaks in the course of reduction of chromium (VI) by glutathione. Mutat Res 216: 19–26, 1989
Hayes RB: Review of occupational epidemiology of chromium chemicals and respiratory cancer. Sci Total Environ 71: 331–339, 1988
Connett PH, Wetterhahn KE: Metabolism of the carcinogenic chromate by cellular constituents. Struct Bond 54: 93–124, 1983
Cohen MD, Kargacin B, Klein CB, Costa M: Mechanism of chromium carcinogenicity and toxicity. Crit Rev Toxicol 23: 255–281, 1983
Ye J, Zhang X, Young HA, Mao Y, Shi X: Chromium (VI)-induced nuclear factor-κB activation in intact cells via free radical reactions. Carcinogenesis 16: 2401–2405, 1995
Chen F, Ding M, Lu Y, Leonard SS, Vallyathan V, Castranova V, Shi X: Participation of MAP kinase p38 and IκB kinase in chromium (VI)-induced NF-κB and AP-1 activation. J Environ Pathol Toxicol Oncol 19: 231–238, 2000
Wang S, Leonard SS, Ye J, Ding M, Shi X: The role of hydroxyl radical as a messenger in Cr (VI)-induced p53 activation. Am J Physiol 279: C868–C875, 2000
Baeuerale PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12: 141–179, 1994
Baldwin AS: The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 14: 649–681, 1996
Ye J, Wang S, Leonard SS, Sun Y, Butterworth L, Antonini J, Ding M, Yongyut Rojanasakul, Vallyathan V, Castranova V, Shi X: Role of reactive oxygen species and p53 in chromium (VI)-induced apoptosis. J Biol Chem 274: 34974–34980, 1999
Shi X, Dong Z, Huang C, Ma W, Liu K, Ye P, Chen F, Leonard SS, Ding M, Castranova V, Vallyathan V: The role of hydroxyl radical as a messenger in the activation of nuclear transcription factor NF-κB. Mol Cell Biochem 194: 63–70, 1999
Tice RR, Strauss GSH, Peters WP: High dose combination alkylating agents with autologous bone-marrow support in patients with breast cancer: Preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay. Mutat Res 271: 101–113, 1992
Chen F, Sun SC, Kuh DC, Gaydos LJ, Demers LM: Essential role of NF-κB activation in silica-induced inflammatory mediator production in macrophages. Biochem Biophys Res Commun 214: 985–992, 1995
Buettner GR: ESR parameters of spin adducts. Free Rad Biol Med 3: 259–303, 1987
Seale J, Kerr JFR, Bishop CJ: Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Ann 17: 229–259, 1982
Vaux DL: Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 90: 786–789, 1993
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, K., HuslerSurname, J., Ye, J. et al. On the mechanism of Cr (VI)‐induced carcinogenesis: Dose dependence of uptake and cellular responses. Mol Cell Biochem 222, 221–229 (2001). https://doi.org/10.1023/A:1017938918686
Issue Date:
DOI: https://doi.org/10.1023/A:1017938918686